Live Evaluations
Healing Inside and Out: Strategies for Treating Psoriatic Disease With Comorbidities: PANP24
About
Healing Inside and Out: Strategies for Treating Psoriatic Disease with Comorbidities
This activity is supported by educational grants from Amgen and Lilly.
Learning Objectives
At the completion of this activity, participants should be better able to:
Review the immunopathologic mechanism of psoriatic disease and associated comorbidities
List key therapies to manage psoriatic disease and associated comorbidities
Select optimal therapies for psoriasis patients based on demographics, comorbidities, and medical history
Describe effective strategies for multidisciplinary care of patients with psoriasis and related comorbidities
Intended Audience
Faculty
Jason Hawkes, MD, MS
Medical Dermatologist
Sacramento/Rocklin, CA
Karan Lal, DO, MS, FAAD
Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ
Lauren Miller, MPAS, PA-C
Southern Skies Dermatology & Surgery
Oxford, AL
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board: Apogee, Arcutis, BI, Blueprint Medicines, BMS, Galderma, Janssen, LEO, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, and UCB
Consultant: Apogee, Arcutis, BI, Blueprint Medicines, BMS, Boxer Capital LLC, Galderma, Institute for Systems Biology (ISB), Janssen, LEO, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, and UCB
Speakers’ Bureau or Honoraria: BMS, BI, Galderma, Regeneron, Sanofi, and UCB
Advisory Board: Incyte, Galderma, Aphyn Biologics, Verrica, Cerave
Speaker's Bureau or Honoraria: Abbvie, Galderma, Incyte, Boehringer, Verrica
Consultant: Abbvie, BMS, Dermavant, EPI, Lilly, Mayne, Novartis, Sanofi Genzyme Regeneron
Speaker's Burea: Abbvie, BMS, Dermavant, Lilly, Sanofi Genzye Regeneron
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.